Intrust Bank Na Neurocrine Biosciences Inc Transaction History

Intrust Bank Na

$936 Million
Q2 2024

A detailed history of Intrust Bank Na transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Intrust Bank Na holds 2,854 shares of NBIX stock, worth $319,305. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,854

Previous 2,928 2.53%

Holding current value

$319,305

Previous $403,000 2.73%

% of portfolio

0.04%

Previous 0.04%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$130.86 - $143.19 $9,683 - $10,596	-74 Reduced 2.53%	2,854 $392,000
Q1 2024 May 09, 2024	SELL	$130.4 - $143.74 $6,389 - $7,043	-49 Reduced 1.65%	2,928 $403,000
Q4 2023 Feb 05, 2024	SELL	$106.07 - $132.76 $72,764 - $91,073	-686 Reduced 18.73%	2,977 $392,000
Q3 2023 Nov 13, 2023	SELL	$94.02 - $117.1 $119,405 - $148,717	-1,270 Reduced 25.74%	3,663 $412,000
Q2 2023 Aug 10, 2023	SELL	$89.53 - $104.87 $32,409 - $37,962	-362 Reduced 6.84%	4,933 $465,000
Q1 2023 May 04, 2023	SELL	$94.11 - $123.02 $45,737 - $59,787	-486 Reduced 8.41%	5,295 $535,000
Q4 2022 Feb 10, 2023	BUY	$106.72 - $127.06 $31,909 - $37,990	299 Added 5.45%	5,781 $690,000
Q3 2022 Nov 09, 2022	BUY	$92.03 - $107.81 $47,763 - $55,953	519 Added 10.46%	5,482 $582,000
Q2 2022 Aug 16, 2022	SELL	$75.79 - $100.07 $96,783 - $127,789	-1,277 Reduced 20.46%	4,963 $484,000
Q1 2022 May 10, 2022	BUY	$72.45 - $94.81 $243,069 - $318,087	3,355 Added 116.29%	6,240 $585,000
Q4 2021 Feb 03, 2022	SELL	$79.65 - $106.22 $77,499 - $103,352	-973 Reduced 25.22%	2,885 $246,000
Q3 2021 Nov 04, 2021	BUY	$86.18 - $99.03 $34,472 - $39,612	400 Added 11.57%	3,858 $370,000
Q2 2021 Aug 05, 2021	BUY	$89.43 - $102.27 $115,454 - $132,030	1,291 Added 59.58%	3,458 $336,000
Q1 2021 Jun 02, 2021	BUY	$87.57 - $119.4 $189,764 - $258,739	2,167 New	2,167 $211,000

Others Institutions Holding NBIX

# of Institutions

641

Shares Held

95.2M

Call Options Held

661K

Put Options Held

227K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $10.7B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Intrust Bank Na with notifications on news.

Account